<DOC>
	<DOC>NCT01884337</DOC>
	<brief_summary>The primary purpose of this protocol is to evaluate the safety of Apixaban in prophylaxis of Venous Thromboembolism (VTE) in Indian patients undergoing elective total knee or hip replacement</brief_summary>
	<brief_title>Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery</brief_title>
	<detailed_description />
	<mesh_term>Apixaban</mesh_term>
	<criteria>Age â‰¥18 years Subjects undergoing elective total knee or hip replacement or a revision of at least one component of a total knee or hip replacement Women who are pregnant or breastfeeding Known or suspected, acquired or bleeding or coagulation disorder in the subject or a first degree relative Active bleeding or at high risk for bleeding. Brain, spinal, ophthalmologic, or major surgery or trauma within the past 90 days other than the elective knee/hip surgery Active hepatobiliary disease Hemoglobin &lt;9 g/dL Platelet count &lt;100,000/mm3 Creatinine clearance &lt;30 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>